MediSieve
Pre-clinicalRemove pathogens, such as harmful cells, bacteria, toxins, and inflammatory cytokines, directly from a patient’s bloodstream
Market Cap
Private
Pipeline
—
Patents
—
Publications
—
Private Company
Total funding raised: $1.7M
About
Remove pathogens, such as harmful cells, bacteria, toxins, and inflammatory cytokines, directly from a patient’s bloodstream
HematologyMedical Devices
Funding History
2Total raised:$1.7M
Seed$1.2MSep 15, 2021
Grant$500KJun 15, 2020